COVID-19 IN A PATIENT WITH HYPER-EOSINOPHILIC SYNDROME TREATED WITH MEPOLIZUMAB

Authors
Category Primary study
JournalAnn. Allergy Asthma Immunol.
Year 2020
This article has no abstract
Epistemonikos ID: cd851348cfd28fdd39db62463eba32e4bf2e949b
First added on: Oct 30, 2020